
Per delivers lecture on p11 at the Allan D. Bass endowed lecture series in Vanderbilt

Translational Research on Neuropharmacology and Movement Disorders
Picture from post lab meeting dinner with Per Andrén’s group at Uppsala university.
PhD student Marcus presenting some of his work on TAAR1 at the ACNP 2023 conference.
Left: Marcus and John A. Allen (University of Texas Medical Branch)
Right: Nina Dedic (Sunovion), Marcus
See PhD student Yachao He’s first author paper about prosaposin and Parkinson’s here
A Phase IIA clinical trial for treating LID using a novel small molecule performed in collaboration with our clinical team has yielded positive results. Click below to download the full press release.